We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Conference To Discuss Lab's Role in Managing Infectious Diseases

By LabMedica International staff writers
Posted on 24 Feb 2009
The American Association of Clinical Chemistry (AACC), the Association of Public Health Laboratories (APHL), and the U.S. More...
Centers for Disease Control & Prevention (CDC; Atlanta, GA, USA) will cosponsor a one-day conference on Tuesday, April 28, 2009, in Atlanta, GA (USA). The conference is titled, "The Lab's Changing Role in Managing Infectious Diseases."

Speakers will discuss recent advances in infectious disease testing, which have provided the core laboratory with opportunities to take a more prominent role in the care of patients with infectious, and sexually transmitted, diseases. The size of the current and future market for ID testing, antimicrobial resistance, validating laboratory tests, emerging molecular platforms, and managing infectious risk in the clinical laboratory are among the topics to be presented at the conference.

The American Association for Clinical Chemistry (AACC; Washington DC, USA) is a professional society dedicated to improving healthcare through laboratory medicine.

The conference is being supported in part by an educational grant from Siemens Healthcare Diagnostics (Deerfield, IL, USA), a leading clinical diagnostics company. Siemens offers products and services designed for efficient delivery of patients test results, for diagnosing medical conditions, and monitoring therapy.

For further information about the conference e-mail Peter Patterson.

Related Links:
Conference Information – Peter Patterson
The American Association for Clinical Chemistry
U.S. Centers for Disease Control & Preventio
Siemens Healthcare Diagnostics



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.